Contribution of three components to individual cancer risk predicting breast cancer risk in Italy

European Journal of Cancer Prevention

Volumn 13, Issue 3, 2004, Pages 183-191

  Boyle, P ^a   Mezzetti, M ^b   La Vecchia, C ^c,d   Franceschi, S ^e   Decarli, A ^f   Robertson, C ^g  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b BOCCONI UNIVERSITY   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^f UNIVERSITY OF BRESCIA   (Italy)

^g UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Alcohol; Anthropometry; Breast neoplasms; Diet; Family history; Hormones; Physical activity; Risk assessment

Indexed keywords

ORAL CONTRACEPTIVE AGENT; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; FAMILY HISTORY; HIGH RISK PATIENT; HUMAN; HYSTERECTOMY; ITALY; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROBABILITY;

ADULT; AGED; ALCOHOL DRINKING; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DIET; EXERCISE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; ITALY; MEDICAL HISTORY TAKING; MIDDLE AGED; MODELS, THEORETICAL; RISK ASSESSMENT;

EID: 2942650882     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cej.0000130014.83901.53     Document Type: Article

References (50)

1. Benichou J, Gail MH (1995). Methods of inference for estimates of absolute risk derived from population-based case-control studies. Biometrics 51: 182-194.
2. Bondy ML, Newman LA (2003). Breast cancer risk assessment models: applicability to African-American women. Cancer 97: 230-235.
3. Breast Cancer Risk Tool (1999). National Cancer Institute. (GENERIC) Ref Type: Computer Program.
4. Breslow NE, Day NE (1980). Statistical Methods in Cancer Research, Vol 1: The Analysis of Case-Control Studies. Lyon: IARC.
5. Bruzzi P, Green SB, Byar DP, et al. (1985). Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol 122: 904-914.
6. Clamp A, Danson S, Clemons M (2002). Hormonal risk factors for breast cancer: identification, chemoprevention, and other intervention strategies. Lancet Oncol 3: 611-619.
7. Costantino JP, Gait MH, Pee D, et al. (1999). Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 91: 1541-1548.
8. D'Avanzo B, Nanni O, La Vecchia C, et al. (1996). Physical activity and breast cancer risk. Cancer Epidemiol Biomarkers Prev 5: 155-160.
9. Decarli A, Franceschi S, Ferraroni M, et al. (1996). Validation of a food-frequency questionnaire to assess dietary intakes in cancer studies in Italy. Results for specific nutrients. Ann Epidemiol 6: 110-118.
10. Doll R, Peto R (1981). The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 66: 1191-1308.
11. Easton DF, Ford D, Bishop DT (1995). Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 56: 265-271.
12. Efron B, Tibshirani RJ (1993). An Introduction to the Bootstrap. New York: Chapman and Hall.
13. Ferraroni M, Decarli A, Franceschi S, et al. (1996). Validity and reproducibility of alcohol consumption in Italy. Int J Epidemiol 25: 775-782.
14. Ferraroni M, Decarli A, Franceschi S, La Vecchia C (1998). Alcohol consumption and risk of breast cancer: a multicentre Italian case-control study. Eur J Cancer 34: 1403-1409.
15. Fisher B, Costantino JP, Wickerham DL, et al. (1998). Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90: 1371-1388.
16. Franceschi S, Barbone F, Negri E, et al. (1995). Reproducibility of an Italian food frequency questionnaire for cancer studies. Results for specific nutrients. Ann Epidemiol 5: 69-75.
17. Franceschi S, Favero A, Decarli A, et al. (1996a). Intake of macronutrients and risk of breast cancer. Lancet 347: 1351-1356.
18. Franceschi S, Favero A, La Vecchia C, et al. (1996b). Body size indices and breast cancer risk before and after menopause. Int J Cancer 67: 181-186.
19. Franceschi S, Parpinel M, La Vecchia C, et al. (1998). Role of different types of vegetables and fruit in the prevention of cancer of the colon, rectum, and breast. Epidemiology 9: 338-341.
20. Freedman AN, Graubard BI, Rao SR, et al. (2003). Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention. J Natl Cancer Inst 95: 526-532.
21. Gail MH, Brinton LA, Byar DP, et al. (1989). Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81: 1879-1886.
22. Gayther SA, Mangion J, Russell P, et al. (1997). Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet 15: 103-105.
23. Higginson J, Muir CS (1979). Environmental carcinogenesis: misconceptions and limitations to cancer control. J Natl Cancer Inst 63: 1791-1798.
24. La Vecchia C, Negri E, Franceschi S, et al. (1995). Hormone replacement treatment and breast cancer risk: a cooperative Italian study. Br J Cancer 72: 244-248.
25. Mezzetti M, Ferraroni M, Decarli A, La Vecchia C, Benichou J (1996). Software for attributable risk and confidence interval estimation in case-control studies. Comput Biomed Res 29: 63-75.
26. Mezzetti M, La Vecchia C, Decarli A, et al. (1998). Population attributable risk for breast cancer: diet, nutrition, and physical exercise. J Natl Cancer Instit 90: 389-394.
27. McTiernan A, Kuniyuki A, Yasui Y, et al. (2001). Comparisons of two breast cancer risk estimates in women with a family history of breast cancer. Cancer Epidemiol Biomarkers Prev 10: 333-338.
28. Muir C, Waterhouse J, Mack T, Powell J, Whelan S (1987). Cancer Incidence in Five Continents, Vol V. Lyon: International Agency for Research on Cancer (IARC Scientific Publication, no. 88).
29. Negri E, La Vecchia C, Franceschi S, et al. (1996). Intake of selected micronutrients and the risk of breast cancer. Int J Cancer 65: 140-144.
30. Negri E, Braga C, La Vecchia C, Franceschi S, Parazzini F (1997). Family history of cancer and risk of breast cancer. Int J Cancer 72: 735-738.
31. Parazzini F, Braga C, La Vecchia C, et al. (1997). Hysterectomy, oophorectomy in premenopause, and risk of breast cancer. Obstet Gynecol 90: 453-456.
32. Parkin DM, Muir CS, Whelan SL, et al. (1993). Cancer Incidence in Five Continents, Vol VI. Lyon: IARC Scientific Publications.
33. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (1997). Cancer Incidence in Five Continents, Vol VII. Lyon: IARC Scientific Publications.
34. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. (2002). Cancer Incidence in Five Continents, Vol VIII. Lyon: IARC Scientific Publications.
35. Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA (2001). Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 93: 358-66.
36. Salvini S, Gnagnarella P, Parpinel M, et al. (1996). The food composition database for an Italian food frequency questionnaire. J Food Composition Analysis 9: 57-71.
37. Schrag D, Kuntz KM, Garber JE, Weeks JC (1997). Decision analysis - effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations [published erratum appears in N Engl J Med 1997 337: 434]. N Engl J Med 336: 1465-1471.
38. Struewing JP, Hartge P, Wacholder S, et al. (1997). The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336: 1401-1408.
39. Talamini R, Franceschi S, La Vecchia C, et al. (1996). The role of reproductive and menstrual factors in cancer of the breast before and after menopause. Eur J Cancer 32A: 303-310.
40. Tartter PI, Gajdos C, Rosenbaum Smith S, Estabrook A, Rademaker AW (2002). The prognostic significance of Gail model risk factors for women with breast cancer. Am J Surg 184: 11-15.
41. Thorlacius S, Struewing JP, Hartge P, et al. (1998). Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet 352: 1337-1339.
42. Veronesi U, Maisonneuve P, Sacchini V, Rotmensz N, Boyle P, Italian Tamoxifen Study Group (2002). Tamoxifen for breast cancer among hysterectomised women. Lancet 359: 1122-1124.
43. Veronesi U, Maisonneuve P, Rotmensz N, et al. (2003). Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk women. J Natl Cancer Inst 95: 160-165.
44. Waterhouse J, Muir CS, Correa P, Powell J (1977). Cancer Incidence in Five Continents, Vol III. Lyon: IARC Scientific Publications.
45. Waterhouse J, Muir CS, Shanmugaratnam K, Powell J (1982). Cancer Incidence in Five Continents. In: Muir CS, Waterhouse J, Mack T, Powell J, Whelan SL (editors): Cancer Incidence in Five Continents, Vol V. Lyon: IARC Scientific Publications.
46. Willett W, Stampfer MJ (1986). Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 124: 17-27.
47. Wynder EL (1952a). Some practical aspects of cancer prevention. N Engl J Med 246: 492-503.
48. Wynder RL (1952b). Some practical aspects of cancer prevention (continued). N Engl J Med 246: 539-46.
49. Wynder EL (1952c). Some practical aspects of cancer prevention (concluded). N Engl J Med 246: 573-84.
50. Zanetti R, Crosignani PX, Rosso S (1997). Cancer in Italy 1988-1992. Roma: Il Pensiero Scientifico Editore.